Taxes Paid
Neurocrine Biosciences Taxes Paid decreased by 96.2% to $300K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 50.0%, from $600K to $300K. Over 3 years (FY 2022 to FY 2025), Taxes Paid shows an upward trend with a 78.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase suggests higher cash outflows for taxes, potentially reducing free cash flow, while a decrease may indicate tax credits, deferred payments, or lower taxable income.
Detailed definition
This metric represents the actual cash outflow for income taxes during the reporting period, as disclosed in the supplem...
Peer comparison
Peer pharmaceutical companies typically report this as a supplemental cash flow item; variations depend on jurisdictional tax rates, R&D tax credits, and the timing of tax installments.
income_taxes_paidHistorical Data
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.8M | $1.7M | $0 | $3.1M | $1.2M | $10.1M | $200K | $3.2M | $1.6M | $46.5M | $200K | $92.6M | $51.7M | $73M | $600K | $71.9M | $1.1M | $7.8M | $300K |
| QoQ Change | — | -5.6% | -100.0% | — | -61.3% | +741.7% | -98.0% | >999% | -50.0% | >999% | -99.6% | >999% | -44.2% | +41.2% | -99.2% | >999% | -98.5% | +609.1% | -96.2% |
| YoY Change | — | — | — | — | -33.3% | +494.1% | — | +3.2% | +33.3% | +360.4% | +0.0% | >999% | >999% | +57.0% | +200.0% | -22.4% | -97.9% | -89.3% | -50.0% |
Taxes Paid at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's taxes paid?
- Neurocrine Biosciences (NBIX) reported taxes paid of $300K in Q1 2026.
- How has Neurocrine Biosciences's taxes paid changed year-over-year?
- Neurocrine Biosciences's taxes paid decreased by 50.0% year-over-year, from $600K to $300K.
- What is the long-term trend for Neurocrine Biosciences's taxes paid?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's taxes paid has grown at a 78.1% compound annual growth rate (CAGR), from $14.4M to $81.4M.
- What does taxes paid mean?
- The total amount of cash the company actually paid to tax authorities during the period.